Pando Biosciences
Pando is a synthetic biology company, leveraging generative AI and high-throughput experiments to discover, optimize, and design high-value biological molecules and systems.
Pando Biosciences operates in advanced therapies based in Boston, MA, USA.
Profile
Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.
Its activity falls under advanced therapies; the profile below is assembled from public directory data.
Boston, MA, USA is where the company is located.
Its current recorded stage is Winter 2023.
Recorded headcount: 5 employees.
Directory analysis
Pando Biosciences is a Boston‑based synthetic biology company that combines generative AI with ultra‑high‑throughput experimentation to discover and engineer enzymes for the pharmaceutical sector. Their platform can screen thousands of enzymes 1000‑fold more efficiently, 75% faster, and 80% cheaper than traditional methods, enabling rapid optimization across multiple properties. The company focuses on delivering tailored, high‑performance enzymes that improve manufacturing efficiency and reduce development costs.
Positioning: Pando positions itself at the intersection of AI and enzyme engineering, targeting pharma’s need for more efficient biocatalysts. With a small, early‑stage team, it is building a technology platform that could complement existing biopharmaceutical development pipelines.
Note: Readers should know that Pando is a nascent biotech focused on AI‑driven enzyme design for pharma.
Auto-generated directory analysis from public data · updated 12 Oct 2026. Informational only, not investment advice.
| Sector | Advanced Therapies |
|---|---|
| Headquarters | Boston, MA, USA |
| Country | USA |
| Employees | 5 |
| Stage | Winter 2023 |
Website: pando.bio
Browse related
Create a free account